HIF1A and neoplasm: In the immune escape phase, tumor cells successfully evade immune surveillance through mechanisms such as downregulation of TAAs, loss or reduced MHC-I expression, activation of epithelial–mesenchymal transition (EMT), metabolic reprogramming via HIF-1α, and increased lactate production, which contribute to immune suppression and tumor progression [31,34,36].